Among the most promising non-incretin receptor targets are amylin (Amy) receptors (AMYRs), supported by data from phase I and phase II clinical trials showing efficacy of the long-acting amylin and calcitonin receptor agonist, cagrilinitide (Cagri), both as monotherapy 2,3 and in combination with the selective GLP-1R agonist, semaglutide 4,5

It may, however, act as a useful bridge in specific circumstances: Recovery from illness or jet lag replenishing nutrients depleted by fever, reduced appetite, or long-haul travel Athletes in heavy training blocks supporting recovery when dietary intake may not keep pace with physiological demand Periods of acute stress and poor eating when B vitamin and magnesium turnover is elevated but intake is low Unexplained fatigue with normal bloodwork when standard panels show nothing actionable but the "flat battery" feeling persists Migraine sufferers particularly those with a known or suspected magnesium component to their episodes Those with compromised gut absorption including people on medications that impair nutrient absorption or those with gastrointestinal conditions If you have a chronic health condition, are pregnant, or are taking prescription medications, consult a licensed doctor before proceeding with any IV therapy

The pills wont work for the same reason that people need to take insulin by injectionthe enzymes in your gut will just chew it up, says Katrin Svensson, PhD, an associate professor of pathology at Stanford University who directs a lab there that does preclinical research on peptides
Continued use enhances and maintains results
Food and Drug Administration has not approved for the treatment of insomnia, sleep disorders, or any other medical condition